Promis Neurosciences (Germany) Analysis

Promis Stock Analysis Notes

About 25.0% of the company shares are owned by insiders or employees . The book value of Promis Neurosciences was presently reported as 3.62. The company recorded a loss per share of 16.98. Promis Neurosciences had not issued any dividends in recent years. The entity had 1:25 split on the 28th of November 2025. ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimers disease , amyotrophic lateral sclerosis , and multiple system atrophy in Canada. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada. PROMIS NEUROSCIENCES operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5 people. For more info on Promis Neurosciences please contact Elliot Goldstein at 416 847 6898 or go to https://www.promisneurosciences.com.

Promis Neurosciences Investment Alerts

Promis Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 725.54 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Promis Neurosciences's market, we take the total number of its shares issued and multiply it by Promis Neurosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

Promis Neurosciences has return on total asset (ROA) of (0.8538) % which means that it has lost $0.8538 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.558) %, meaning that it generated substantial loss on money invested by shareholders. Promis Neurosciences' management efficiency ratios could be used to measure how well Promis Neurosciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Promis Neurosciences' Total Current Assets are most likely to increase significantly in the upcoming years. The Promis Neurosciences' current Intangible Assets is estimated to increase to about 44 K, while Other Current Assets are projected to decrease to roughly 30.3 K.

Technical Drivers

As of the 8th of February, Promis Neurosciences holds the Semi Deviation of 4.77, coefficient of variation of 1363.78, and Risk Adjusted Performance of 0.0678. Promis Neurosciences technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check Promis Neurosciences downside deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Promis Neurosciences is priced some-what accurately, providing market reflects its current price of 10.9 per share.

Promis Neurosciences Price Movement Analysis

Promis Neurosciences Outstanding Bonds

Promis Neurosciences Predictive Daily Indicators

Promis Neurosciences Forecast Models

Promis Neurosciences' time-series forecasting models are one of many Promis Neurosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Promis Neurosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Promis Neurosciences Debt to Cash Allocation

Promis Neurosciences has accumulated 2.42 M in total debt with debt to equity ratio (D/E) of 0.66, which is about average as compared to similar companies. Promis Neurosciences has a current ratio of 18.69, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Promis Neurosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Promis Neurosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Promis Neurosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Promis to invest in growth at high rates of return. When we think about Promis Neurosciences' use of debt, we should always consider it together with cash and equity.

Promis Neurosciences Total Assets Over Time

Promis Neurosciences Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Promis Neurosciences' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Promis Neurosciences, which in turn will lower the firm's financial flexibility.

Promis Neurosciences Corporate Bonds Issued

Stock analysis is the technique used by a trader or investor to examine and evaluate how Promis Neurosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Promis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Promis Neurosciences. By using and applying Promis Stock analysis, traders can create a robust methodology for identifying Promis entry and exit points for their positions.

When running Promis Neurosciences' price analysis, check to measure Promis Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Promis Neurosciences is operating at the current time. Most of Promis Neurosciences' value examination focuses on studying past and present price action to predict the probability of Promis Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Promis Neurosciences' price. Additionally, you may evaluate how the addition of Promis Neurosciences to your portfolios can decrease your overall portfolio volatility.